• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Genpact Limited filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    5/28/25 4:27:07 PM ET
    $G
    Professional Services
    Consumer Discretionary
    Get the next $G alert in real time by email
    g-20250522
    0001398659FALSE00013986592025-05-222025-05-22

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): May 22, 2025
    GENPACT LIMITED
    (Exact name of registrant as specified in its charter)
    Bermuda     001-3362698-0533350
    (State or other jurisdiction
    of incorporation)
       (Commission
         File Number)
    (I.R.S. Employer
    Identification No.)
    Canon's Court, 22 Victoria Street
    Hamilton HM 12, Bermuda
    (Address of Principal Executive Offices) (Zip Code)
    Registrant's telephone number, including area code: (441) 298-3300
    Not Applicable
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each classTrading SymbolName of each exchange on which registered
    Common shares, par value $0.01 per shareGNew York Stock Exchange
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 5.07    Submission of Matters to a Vote of Security Holders
    On May 22, 2025, Genpact Limited, a Bermuda company (the “Company”), held its 2025 annual general meeting of shareholders (the “Annual Meeting”) at 521 Fifth Avenue, 14th Floor, New York, NY. At the Annual Meeting, Company shareholders voted on three proposals. The full results of the votes are set forth below. Each proposal is described in detail in the Company’s previously filed Proxy Statement related to the Annual Meeting.
    Proposal 1

    Company shareholders elected each of the nominees to the Company’s Board of Directors as set forth below:
    Director
    Number of Shares For
    Number of Shares Against

    Number of Shares Abstaining

    Broker Non-Votes
    Balkrishan Kalra
    144,402,162397,864124,7789,318,517
    James Madden
    142,588,4402,209,219127,1459,318,517
    Ajay Agrawal
    144,038,647721,046165,1119,318,517
    Laura Conigliaro
    142,602,0042,196,913125,8879,318,517
    Tamara Franklin
    144,537,798260,946126,0609,318,517
    Nicholas Gangestad
    144,766,23228,357130,2159,318,517
    Carol Lindstrom
    143,401,5911,358,602164,6119,318,517
    CeCelia Morken
    144,530,480261,284133,0409,318,517
    Brian Stevens
    144,769,30528,495127,0049,318,517
    Mark Verdi
    143,304,8961,491,259128,6499,318,517

    Proposal 2

    Company shareholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as set forth below:

    Votes cast in favor
    132,959,370
    Votes cast against
    11,618,993
    Votes abstaining
    346,441
    Broker non-votes
    9,318,517

    Proposal 3

    Company shareholders approved the appointment of KPMG Assurance and Consulting Services LLP as the Company’s independent registered public accounting firm for the 2025 fiscal year as set forth below:

    Votes cast in favor
    146,281,029
    Votes cast against
    7,841,249
    Votes abstaining
    121,043



    Signature
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
      GENPACT LIMITED
         
    Date: May 28, 2025 By: /s/ Heather D. White
      Name: Heather D. White
      Title: Senior Vice President, Chief Legal Officer and Secretary

    Get the next $G alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $G

    DatePrice TargetRatingAnalyst
    2/7/2025$45.00 → $60.00Hold → Buy
    TD Cowen
    1/21/2025$44.00 → $55.00Hold → Buy
    Jefferies
    7/17/2024$43.00 → $40.00Underweight → Neutral
    JP Morgan
    1/30/2024$40.00Neutral
    Mizuho
    12/15/2023$38.00Outperform → Neutral
    Robert W. Baird
    8/22/2023$40.00Neutral → Underweight
    JP Morgan
    7/18/2023$46.00 → $42.00Buy → Neutral
    Citigroup
    12/15/2022$55.00 → $50.00Overweight → Neutral
    JP Morgan
    More analyst ratings

    $G
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Genpact upgraded by TD Cowen with a new price target

      TD Cowen upgraded Genpact from Hold to Buy and set a new price target of $60.00 from $45.00 previously

      2/7/25 7:07:51 AM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact upgraded by Jefferies with a new price target

      Jefferies upgraded Genpact from Hold to Buy and set a new price target of $55.00 from $44.00 previously

      1/21/25 7:48:14 AM ET
      $G
      Professional Services
      Consumer Discretionary
    • Genpact upgraded by JP Morgan with a new price target

      JP Morgan upgraded Genpact from Underweight to Neutral and set a new price target of $40.00 from $43.00 previously

      7/17/24 7:53:33 AM ET
      $G
      Professional Services
      Consumer Discretionary